Middle East & Africa Travel Vaccine Market to 2032
Overview
The Middle East & Africa Travel Vaccine Market is expected to reach a 1,185.03 USD Million by 2032 and is projected to grow at a CAGR of 9.03% from 2025 to 2032.
Revenue, 2024 (USD Million)
685.43
Forecast, 2032 (USD Million)
1,185.03
CAGR, 2024 - 2032
9.03%
Report Coverage
Middle East & Africa
Middle East & Africa Travel Vaccine Market 2018-2032 USD Million
Middle East & Africa Travel Vaccine Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 685.43 USD Million
- Projected Market Size (2032): 1,185.03 USD Million
- CAGR (2025-2032): 9.03%
Key Findings of Middle East & Africa Travel Vaccine Market
- The Middle East & Africa Travel Vaccine Market was valued at 1,185.03 USD Million in 2024.
- The Middle East & Africa Travel Vaccine Market is likely to grow at a CAGR of 9.03% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Injectable in Route of Administration Segment accounted for the largest share of the market with a revenue of 569.67 USD Million
- The fastest growing segment Typhoid in Disease Segment grew Fastest with a CAGR of 14.38% during the forecast period from 2024 to 2032.
Middle East & Africa Travel Vaccine Market Scope
Middle East & Africa Travel Vaccine Market Segmentation & Scope
Type
- Viral Vector Vaccines
- DNA Vaccines
- Toxoid Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide and Conjugate Vaccines
- Inactivated Vaccines
Composition
- Mono Vaccines
- Combination Vaccines
Category
- Required Vaccine
- Routine Vaccine
- Recommended Vaccine
Disease
- COVID-19
- Others
- Polio
- Malaria
- Tick-Borne Encephalitis
- Measles and Mumps
- DPT
- Rabies
- Yellow Fever
- Meningococcal Meningitis
- Japanese Encephalitis
- Influenza
- Varicella
- Cholera
- Hepatitis
- Typhoid
Distribution Channel
- B2C
- B2B
Age Group
- Above 50 Years
- Less than 20 Years
- 20-50 Years
Patient Type
- Geriatric
- Pediatric
- Adult
Gender
- Female
- Male
Route of Administration
- Oral
- Injectable
Middle East & Africa Travel Vaccine Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 685.43 USD Million |
| Market Value in 2032 | 1,185.03 USD Million |
| CAGR (2025-2032) | 9.03% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Type,Composition,Category,Disease,Distribution Channel,Age Group,Patient Type,Gender,Route of Administration |
Regional Insights:
-
Leading Market (2024-2032): Middle East & Africa, leading in terms of revenue 685.43 USD Million in 2024
- Key Country: Saudi Arabia, leading in terms of revenue with value of 179.78 USD Million in 2024.
Segments and Scope
-
Middle East & Africa Travel Vaccine Market to 2032, By Type
- Inactivated Vaccines is the largest segment in Middle East & Africa Travel Vaccine Market to 2032 with a revenue of 229.79 USD Million in the year 2024.
- Inactivated Vaccines is the Fastest growing segment in Middle East & Africa Travel Vaccine Market to 2032 with a Growth rate of 9.92 % in forecast period 2025-2032.
-
Middle East & Africa Travel Vaccine Market to 2032, By Composition
- Combination Vaccines is the largest segment in Middle East & Africa Travel Vaccine Market to 2032 with a revenue of 486.43 USD Million in the year 2024.
- Combination Vaccines is the Fastest growing segment in Middle East & Africa Travel Vaccine Market to 2032 with a Growth rate of 9.17 % in forecast period 2025-2032.
-
Middle East & Africa Travel Vaccine Market to 2032, By Category
- Recommended Vaccine is the largest segment in Middle East & Africa Travel Vaccine Market to 2032 with a revenue of 346.73 USD Million in the year 2024.
- Recommended Vaccine is the Fastest growing segment in Middle East & Africa Travel Vaccine Market to 2032 with a Growth rate of 9.39 % in forecast period 2025-2032.
-
Middle East & Africa Travel Vaccine Market to 2032, By Disease
- Typhoid is the largest segment in Middle East & Africa Travel Vaccine Market to 2032 with a revenue of 160.58 USD Million in the year 2024.
- Typhoid is the Fastest growing segment in Middle East & Africa Travel Vaccine Market to 2032 with a Growth rate of 14.38 % in forecast period 2025-2032.
-
Middle East & Africa Travel Vaccine Market to 2032, By Distribution Channel
- B2B is the largest segment in Middle East & Africa Travel Vaccine Market to 2032 with a revenue of 541.63 USD Million in the year 2024.
- B2B is the Fastest growing segment in Middle East & Africa Travel Vaccine Market to 2032 with a Growth rate of 9.18 % in forecast period 2025-2032.
-
Middle East & Africa Travel Vaccine Market to 2032, By Age Group
- 20-50 Years is the largest segment in Middle East & Africa Travel Vaccine Market to 2032 with a revenue of 366.15 USD Million in the year 2024.
- 20-50 Years is the Fastest growing segment in Middle East & Africa Travel Vaccine Market to 2032 with a Growth rate of 9.44 % in forecast period 2025-2032.
-
Middle East & Africa Travel Vaccine Market to 2032, By Patient Type
- Adult is the largest segment in Middle East & Africa Travel Vaccine Market to 2032 with a revenue of 337.77 USD Million in the year 2024.
- Adult is the Fastest growing segment in Middle East & Africa Travel Vaccine Market to 2032 with a Growth rate of 9.59 % in forecast period 2025-2032.
-
Middle East & Africa Travel Vaccine Market to 2032, By Gender
- Male is the largest segment in Middle East & Africa Travel Vaccine Market to 2032 with a revenue of 383.61 USD Million in the year 2024.
- Male is the Fastest growing segment in Middle East & Africa Travel Vaccine Market to 2032 with a Growth rate of 9.22 % in forecast period 2025-2032.
-
Middle East & Africa Travel Vaccine Market to 2032, By Route of Administration
- Injectable is the largest segment in Middle East & Africa Travel Vaccine Market to 2032 with a revenue of 569.67 USD Million in the year 2024.
- Injectable is the Fastest growing segment in Middle East & Africa Travel Vaccine Market to 2032 with a Growth rate of 9.17 % in forecast period 2025-2032.
Middle East & Africa Travel Vaccine Market Company Share Analysis
| Company Name |
|
||
| Merck & Co., Inc. | |||
| Johnson & Johnson Services, Inc. | |||
| Pfizer Inc. | |||
| Sanofi | |||
| GSK plc. | |||
Middle East & Africa Travel Vaccine Market Geographical Sales Distribution, 2018-2032 USD Million
Middle East & Africa Travel Vaccine Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Middle East & Africa Travel Vaccine Market is segmented based on Segmentation Type,Composition,Category,Disease,Distribution Channel,Age Group,Patient Type,Gender,Route of Administration.
Middle East & Africa Travel Vaccine Market was valued at USD 685.43(Revenue in USD Million) in 2022.
Middle East & Africa Travel Vaccine Market is projected to grow at a CAGR of 9.03% during the forecast period of 2024 to 2032.
The Injectable segment is expected to dominate the Middle East & Africa Travel Vaccine Market, holding a largest market share of 569.67 USD Million in 2024
Middle East & Africa Travel Vaccine Market Scope
Middle East & Africa Travel Vaccine Market Segmentation & Scope
Type
- Viral Vector Vaccines
- DNA Vaccines
- Toxoid Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide and Conjugate Vaccines
- Inactivated Vaccines
Composition
- Mono Vaccines
- Combination Vaccines
Category
- Required Vaccine
- Routine Vaccine
- Recommended Vaccine
Disease
- COVID-19
- Others
- Polio
- Malaria
- Tick-Borne Encephalitis
- Measles and Mumps
- DPT
- Rabies
- Yellow Fever
- Meningococcal Meningitis
- Japanese Encephalitis
- Influenza
- Varicella
- Cholera
- Hepatitis
- Typhoid
Distribution Channel
- B2C
- B2B
Age Group
- Above 50 Years
- Less than 20 Years
- 20-50 Years
Patient Type
- Geriatric
- Pediatric
- Adult
Gender
- Female
- Male
Route of Administration
- Oral
- Injectable
Frequently Asked Questions
The Middle East & Africa Travel Vaccine Market is segmented based on Segmentation Type,Composition,Category,Disease,Distribution Channel,Age Group,Patient Type,Gender,Route of Administration.
Middle East & Africa Travel Vaccine Market was valued at USD 685.43(Revenue in USD Million) in 2022.
Middle East & Africa Travel Vaccine Market is projected to grow at a CAGR of 9.03% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Travel Vaccine Market for final year is USD 1,185.03 (USD Million).
Middle East & Africa Travel Vaccine Market Company Profiling
Frequently Asked Questions
The Middle East & Africa Travel Vaccine Market is segmented based on Segmentation Type,Composition,Category,Disease,Distribution Channel,Age Group,Patient Type,Gender,Route of Administration.
Middle East & Africa Travel Vaccine Market was valued at USD 685.43(Revenue in USD Million) in 2022.
Middle East & Africa Travel Vaccine Market is projected to grow at a CAGR of 9.03% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Travel Vaccine Market for final year is USD 1,185.03 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.